Cell-free Fetal Nucleic Acid Identifier Markers in Maternal Circulation
Open Access
- 1 January 2017
- journal article
- review article
- Published by Medknow in Advanced Biomedical Research
- Vol. 6 (1), 89
- https://doi.org/10.4103/2277-9175.211800
Abstract
From the discovery of cell-free fetal (cff)-DNA in 1997 so far, many studies have been performed on various aspects of cff-nucleic acid. It is undoubted that currently, invasive prenatal diagnosis progresses to the noninvasive test. However, there are many problems. One of the most challenging issues in this field is differentiation and detection of the small amount of cff-nucleic acid in maternal plasma. Many markers and methods have been used for this purpose. This review makes an attempt to review and compare the studies in the field. Six identifier markers including Y-specific sequence, polymorphisms, epigenetic difference, DNA size difference, fetal mRNA, and microRNA as well as the advantages and disadvantages of each marker are discussed. This review provides a relatively perfect set on cff-nucleic acid biomarkers in various physiological and pathological status of pregnancy, helping to review and compare the prior obtained results, and improving designation in future studies.Keywords
This publication has 72 references indexed in Scilit:
- Evaluation of a Novel Assay for Detection of the Fetal Marker RASSF1A: Facilitating Improved Diagnostic Reliability of Noninvasive Prenatal DiagnosisPLOS ONE, 2012
- Epigenetic approaches for the detection of fetal DNA in maternal plasmaChimerism, 2010
- Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospectsPrenatal Diagnosis, 2008
- Specific tumour-associated methylation in normal human term placenta and first-trimester cytotrophoblastsMolecular Human Reproduction, 2008
- Application of maternal plasma DNA analysis for noninvasive prenatal diagnosis of Hb E-β-thalassemiaTranslational Research, 2007
- Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblastPrenatal Diagnosis, 2007
- Treatment of Maternal Blood Samples with Formaldehyde Does Not Alter the Proportion of Circulatory Fetal Nucleic Acids (DNA and mRNA) in Maternal PlasmaClinical Chemistry, 2005
- Detection of Paternally Inherited Fetal Point Mutations for β-Thalassemia Using Size-Fractionated Cell-Free DNA in Maternal PlasmaJAMA, 2005
- Size Separation of Circulatory DNA in Maternal Plasma Permits Ready Detection of Fetal DNA PolymorphismsClinical Chemistry, 2004
- Increased Fetal DNA Concentrations in the Plasma of Pregnant Women Carrying Fetuses with Trisomy 21Clinical Chemistry, 1999